Ola Bratt (Former)
31 – 40 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
Clinical Management of Prostate Cancer in Men with BRCA Mutations.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Towards "next-generation" prostate cancer screening.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Serum markers in prostate cancer detection.
(
- Contribution to journal › Article
-
Mark
The risk of distant metastases and cancer-specific survival in men with serum prostate-specific antigen values above 100 ng/ml.
(
- Contribution to journal › Article
- 2014
-
Mark
(18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
The Clinical Impact of Genetic Susceptibility to Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial